Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicaid AMPs Exclude PBM Discounts Outside Of Mail Order – Final Rules

This article was originally published in The Pink Sheet Daily

Executive Summary

Citing potential antitrust violations and other concerns, CMS also narrows it definition for how sales of “authorized generics” are reported for average manufacturer prices.

You may also be interested in...



Pharmacy Groups File Suit To Stop New Medicaid Drug Payment System

Pharmacies could lose $8 billion over next five years if data used to set average manufacturer prices includes mail-order, clinic and physician sales, trade groups assert.

Pharmacy Groups File Suit To Stop New Medicaid Drug Payment System

Pharmacies could lose $8 billion over next five years if data used to set average manufacturer prices includes mail-order, clinic and physician sales, trade groups assert.

Medicaid AMP Rule Implementation Delay Requested By PhRMA, BIO, GPhA

Groups send joint letter to CMS urging delay in average manufacturer price methodology.

Topics

UsernamePublicRestriction

Register

LL1135415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel